Home Topics Food and Drug Administration

Food and Drug Administration

10. The NCDC and partners, with leadership from the Federal Ministry of Health and Presidential Task Force (PTF) on COVID-19 is putting in place measures to strengthen the public health response to the pandemic.

Coronavirus: NCDC discharges 65, total recoveries now 154,643

The Nigeria Centre for Disease Control (NCDC) has discharged additional 65 people after testing negative to the COVID-19 virus following treatment in the country.
The United States should resume use of the Johnson & Johnson COVID-19 vaccine for all adults, an independent advisory committee to the Centers for Disease Control and Prevention (CDC) said today.

US: CDC committee backs Johnson & Johnson coronavirus vaccine

The United States should resume use of the Johnson & Johnson COVID-19 vaccine for all adults, an independent advisory committee to the Centers for Disease Control and Prevention (CDC) said today. There is a small risk of a rare type of blood clot in women under 50, and health officials should warn patients of that risk, the committee stressed during its deliberations.
Johnson & Johnson's single dose COVID-19 shot is the fourth to be endorsed for use in the EU after vaccines from Pfizer-BioNTech, AstraZeneca-Oxford University and Moderna.

South Africa suspends J&J vaccine rollout

South Africa on Tuesday suspended the rollout of the Johnson & Johnson Covid-19 vaccine over potential blood clot risks reported by the United States, the health minister said.
Pharmacists prepare syringes with the Johnson & Johnson vaccine for Covid-19 in Detroit on Monday.Nicole Hester/Ann Arbor News, via Associated Press

U.S. calls for pause on Johnson & Johnson vaccine after clotting cases

Federal health agencies on Tuesday called for an immediate pause in use of Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination.
The Africa Centres for Disease Control and Prevention (Africa CDC) has advised African countries against the use of Ivermectin for treating COVID-19.

WHO, others warn against use of Ivermectin to treat coronavirus patients

The World Health Organisation, WHO has joined the growing list of health bodies warning against the use of the generic anti-parasite drug ivermectin in patients with COVID-19 except for clinical trials, because of a lack of data demonstrating its benefits.
Amazon received Food and Drug Administration authorisation for a Covid-19 test made by itssubsidiary STS Lab Holdco, and it plans to use it for its onsite coronavirus testing programs.

Amazon gets FDA authorisation for at-home coronavirus test kit

Amazon received Food and Drug Administration authorisation for a Covid-19 test made by itssubsidiary STS Lab Holdco, and it plans to use it for its onsite coronavirus testing programs.
FILE PHOTO - Vials labelled Astra Zeneca COVID-19 Coronavirus Vaccine and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS-Dado Ruvic-Illustration-File Photo

AstraZeneca says vaccine 76% effective in updated US trial data

British-Swedish drugmaker AstraZeneca on Wednesday revised down by three percentage points the effectiveness of its Covid vaccine after American authorities raised concerns that results reported from its US trial were outdated.
A study in the United States, shows AstraZeneca’s COVID-19 vaccine provides strong protection against coronavirus and eliminates hospitalizations and deaths from the disease across all age groups, the company announced on Monday.

US study shows AstraZeneca effective for all ages

A study in the United States, shows AstraZeneca’s COVID-19 vaccine provides strong protection against coronavirus and eliminates hospitalizations and deaths from the disease across all age groups, the company announced on Monday.
Johnson & Johnson vaccine vials at the Klerksdorp Hospital in South Africa. Photo by Phill Magakoe - AFP via Getty Images

FDA: Johnson & Johnson’s single-shot coronavirus vaccine effective

The one-dose COVID-19 vaccine made by Johnson & Johnson protects against severe disease and has no serious safety concerns, according to a new analysis published today by the US Food and Drug Administration. The report takes the vaccine one step closer to authorization by the agency, meaning the United States could have a third shot available in a matter of days.

Coronavirus: Prof. Maurice Iwu restates efficacy of herbal medicine

Bioresources Development Group (BDG) chairman, Prof. Maurice Iwu has restated the efficacy of herbal medicine in the treatment of the COVID-19 cases as the virus enters variant stage globally.
A small shopping basket filled with vials labeled COVID-19 - Coronavirus Vaccine and medical sryinges are placed on a Moderna logo in this illustration taken November 29, 2020. Picture taken November 29, 2020. REUTERS-Dado Ruvic-Ilustration

Moderna, McKesson, U.S. Army general begin rolling out new coronavirus vaccine

Distribution of Moderna Inc’s COVID-19 vaccine to more than 3,700 locations in the United States has begun, vastly widening the rollout started last week by Pfizer Inc, U.S Army General Gustave Perna said on Saturday.
FILE PHOTO - Vials with a sticker reading, COVID-19 - Coronavirus vaccine - Injection only and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS-Dado Ruvic-Illustration-File Photo

U.S. gets second coronavirus vaccine

The U.S. Food and Drug Administration (FDA) on Friday approved for emergency use a second coronavirus vaccine produced by American biotechnology company, Moderna.
U.S. Vice President Mike Pence receives the COVID-19 vaccine at the White House in Washington, U.S., December 18, 2020. REUTERS-Cheriss May

Mike Pence gets COVID shot on TV as U.S. about to approve second vaccine

U.S. Vice President Mike Pence received his COVID-19 vaccine live on television on Friday, seeking to shore up public support for vaccinations as U.S. regulators were on the cusp of approving a second vaccine for emergency use.
FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

Johnson & Johnson enrolls about 45,000 participants for late-stage coronavirus vaccine trial

Johnson & Johnson said on Thursday it has enrolled about 45,000 participants for the first late-stage trial of its COVID-19 single-dose vaccine candidate and that it expects interim data by late-January.
An independent committee of experts recommended that the Food and Drug Administration authorize the Moderna COVID-19 vaccine for people 18 and older.

Moderna vaccine gets sign-off from US FDA committee

An independent committee of experts recommended that the Food and Drug Administration authorize the Moderna COVID-19 vaccine for people 18 and older. This is the second COVID-19 vaccine to go before the committee — the first, made by Pfizer and BioNTech, was authorized last week.
Justin Sambol, right, Senior Associate Dean for Clinical Affairs, receives the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine from Ambulatory Care Technician Sady Ferguson, at Rutgers New Jersey Medical School for COVID-19 at University Hospital in Newark, New Jersey, U.S., December 15, 2020. Kirsten Luce/Pool via REUTERS

U.S. vaccine reaches more workers on pandemic’s front lines

The United States extended its rollout of the first authorized COVID-19 vaccine on Tuesday, inoculating healthcare workers as part of a massive campaign to protect all Americans and contain a U.S. outbreak that has killed more than 300,000 people.
FILE PHOTO - Vials with a sticker reading, COVID-19 - Coronavirus vaccine - Injection only and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS-Dado Ruvic-Illustration

Moderna vaccine safe and effective – US experts

The analysis by the Food and Drug Administration’s (FDA) means it could become the second coronavirus vaccine to be allowed in the US.
FILE PHOTO - Vials with a sticker reading, COVID-19 - Coronavirus vaccine - Injection only and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS-Dado Ruvic-Illustration

Moderna’s coronavirus vaccine clears first U.S. FDA hurdle

Moderna Inc’s COVID-19 vaccine appeared to be set for regulatory authorization this week after U.S. Food and Drug Administration staff members did not raise any major new concerns about it in documents released on Tuesday.
The US public will start receiving the Pfizer-BioNTech coronavirus vaccine from Monday after it was authorised for emergency use, officials say.

EU regulator set to approve Pfizer/BioNTech coronavirus vaccine on December 23

The European Medicines Agency (EMA) is set to approve its first COVID-19 vaccine on Dec. 23, a German government source told Reuters on Tuesday, putting EU countries on track to start to catch up with the United States and Britain, where immunisation campaigns are under way.
Even as United States have continued to harvest huge numbers of deaths and hospitalization occasioned by novel Coronavirus (Covid-19) infections, hope has come for victims as the first Covid-19 vaccines shipment in American soil have left Kalamazoo factory of one of the world’s drugs manufacturing companies Pfizer.

First US coronavirus vaccine shipment leaves Pfizer Michigan facility

Even as United States have continued to harvest huge numbers of deaths and hospitalization occasioned by novel Coronavirus (Covid-19) infections, hope has come for victims as the first Covid-19 vaccines shipment in American soil have left Kalamazoo factory of one of the world’s drugs manufacturing companies Pfizer.
The US public will start receiving the Pfizer-BioNTech coronavirus vaccine from Monday after it was authorised for emergency use, officials say.

US public to receive Pfizer vaccinations from Monday

The US public will start receiving the Pfizer/BioNTech coronavirus vaccine from Monday after it was authorised for emergency use, officials say.
“We worked quickly based on the urgency of this pandemic, not because of any other external pressure,” U.S. Food and Drug Administration Commissioner Stephen Hahn said during a press conference.

U.S. reassures Americans coronavirus vaccine is safe

With Pfizer Inc's and BioNTech SE's BNTX.O COVID-19 vaccine distribution imminent after U.S. authorization on Friday, top regulators sought to reassure Americans that the record fast pace was warranted and had not sacrificed safety.

Recent Stories

Leicester City veteran Wes Morgan admits winning the FA Cup may be the ideal way to say goodbye to the club.

Wes Morgan hints at leaving Leicester after FA Cup triumph

Leicester City veteran Wes Morgan admits winning the FA Cup may be the ideal way to say goodbye to the club.

Fire guts INEC headquarters in Enugu

The Independent National Electoral Commission (INEC) headquarters in Enugu was on Sunday night gutted by fire barely one week after the office in Obollo-Afor, Udenu was razed.
Sheikh Ahmad Gumi says the easiest and safest way to end insecurity in the north is to negotiate peace with the bandits that have turned the region into a killing field.

Sheikh Gumi: Many Boko Haram commanders willing to surrender

Kaduna-based Islamic cleric, Sheikh Ahmad Gumi, has revealed that several Boko Haram commanders are willing to surrender and urged the federal government to use proper engagement to negotiate with the group.
Paris St Germain clung on to their hopes of winning a fourth consecutive Ligue 1 title with a 4-0 home win against 10-man Stade de Reims as Lille’s lead was cut to a single point with one game remaining on Sunday.

Ligue 1: PSG cling on to title hopes as leaders Lille held

Paris St Germain clung on to their hopes of winning a fourth consecutive Ligue 1 title with a 4-0 home win against 10-man Stade de Reims as Lille’s lead was cut to a single point with one game remaining on Sunday.

Edwin Clark cautions against agitation for Nigeria’s break-up

An elder statesman and former Minister of Information, Chief Edwin Clark, has cautioned against calls for secession in some parts of the country.

Most Popular

Sam Allardyce: Premier League is becoming boring

Sam Allardyce has warned that the Premier League is in danger of becoming boring because teams have been "brainwashed" into using the same playing style.
Minister for Foreign Affairs, Geoffrey Onyeama has said that the Nigerian Government would use the Forum of the UN General Assembly (UNGA) to seek global support fighting terrorism and increasing Foreign Direct Investments (FDI).

Israel-Palestine crisis: Nigeria asks parties to de-escalate hostilities

Amidst growing crisis between the State of Israel and the State of Palestine, the Federal Government of Nigeria, has called on both sides to de-escalate hostilities.
1620793910

Kogi: Bridge collapses days after completion

A multi million Naira bridge constructed in Kogi State has collapsed about a week after it was completed. The Kogi State Government has frowned at the development insisting the Contractor must reconstruct the bridge.

SEC bars unregistered operators from capital market after May 31

The Securities and Exchange Commission, SEC, has declared that Capital Market Operators, CMO, who fail to renew their registration before May 31, 2021, will not be allowed to operate in the market.
Officials of the Nigerian Security and Civil Defence Corps (NSCDC) in Kaduna State on Thursday rescued eight kidnap victims during an operation in the state capital.

NSCDC arrests alleged serial rapist suspect

The Nigeria Security and Civil Defence Corps (NSCDC) in Sokoto State has arrested a 30-year-old alleged serial rapist suspect.